广发纳斯达克生物科技人民币(001092)

动态评分: 5.30分

投资组合

报告日期 名称 比例
2023-12-31 Apellis Pharmaceuticals Inc 0.66%
2023-12-31 BridgeBio Pharma Inc 0.65%
2023-12-31 Intra-Cellular Therapies Inc 0.64%
2023-12-31 Immunovant Inc 0.56%
2023-12-31 Vaxcyte Inc 0.55%
2023-12-31 Blueprint Medicines Corp 0.52%
2023-12-31 阿卡迪亚 0.48%
2023-12-31 CRISPR Therapeutics AG 0.46%
2023-12-31 奥洛兹美医疗 0.45%
2023-12-31 Legend Biotech Corp ADR 0.44%
2023-12-31 Revolution Medicines Inc 0.43%
2023-12-31 阿尔凯默斯 0.43%
2023-12-31 Madrigal Pharmaceuticals Inc 0.42%
2023-12-31 Insmed Inc 0.41%
2023-12-31 Nuvalent Inc-A 0.39%
2023-12-31 Mirati Therapeutics Inc 0.38%
2023-12-31 爱美医疗 0.38%
2023-12-31 Ultragenyx Pharmaceutical Inc 0.36%
2023-12-31 Axsome Therapeutics Inc 0.35%
2023-12-31 Krystal Biotech Inc 0.32%

投资模拟

公告&资料